Proscar is one of the more internationally available urological preparations, marketed in 42 countries. Its active ingredient is finasteride, a medication classified within the urological and antiandrogenic categories and used in the management of prostate-related conditions. This page is written for the international reader — a traveller, expatriate, or family member trying to identify Proscar abroad or recognise it under a different label.
Proscar is prescribed in the management of benign prostatic hyperplasia, the non-cancerous enlargement of the prostate gland that can interfere with urinary flow and lead to urinary retention. It is also referenced in connection with surgical settings, including prostatectomy and transurethral resection of the prostate. The structured indication list further down this page details the registered uses recognised across the markets where Proscar is sold.
Because Proscar is widely distributed, travellers and expatriates frequently encounter the same medication abroad — sometimes under the Proscar brand, sometimes as a finasteride-containing generic. Markets where Proscar is registered include Brazil, Germany, China, Canada, and Egypt, but regulatory packaging, prescription pathways, and tablet strengths vary considerably from one country to another. A pharmacist in any of these markets can confirm whether a locally stocked finasteride product corresponds to what the patient has been taking at home.
Other medications used in the management of benign prostatic hyperplasia exist worldwide under different molecules and brand names, and the broader urological and antiandrogenic categories are well represented in most regulated markets. Any decision about starting, continuing, or substituting finasteride is properly made with a healthcare provider, and a local pharmacist is usually the right first contact to clarify regional brand names and availability.
Proscar is prescribed in the management of benign prostatic hyperplasia, a non-cancerous enlargement of the prostate gland that can interfere with urinary function. It is also referenced in connection with urinary retention and with surgical contexts such as prostatectomy and transurethral resection of the prostate. The structured indication block below this introduction details each registered use as recognised in the markets where Proscar is sold.
Proscar contains finasteride, a urological agent with antiandrogenic activity used in the management of prostate-related conditions. Finasteride is the same molecule whether sold under the Proscar brand or as a generic, and internationally the same active ingredient circulates under multiple commercial names, particularly in markets where the original patent has expired and several manufacturers produce finasteride products in parallel.
Proscar carries marketing authorisation in 42 countries across a broad geographic spread, including Brazil, Germany, Australia, Canada, China, Egypt, and Finland. The footprint covers parts of Europe, the Americas, Asia, North Africa, and Oceania. If your country is not represented in the structured list further down this page, a local pharmacist can usually confirm whether finasteride is available in that market under another brand name or as a generic.
Finasteride is sold under several brand names worldwide and is widely available as a generic in markets where the original patent has expired. Other agents within the broader urological and antiandrogenic categories used for prostate-related conditions also exist, although they are not freely interchangeable — molecules within a therapeutic area can have meaningfully different profiles. To identify a local finasteride-containing product, search the active ingredient on Pill2Trip or speak to a pharmacist.
Proscar is a prescription medication in essentially every market where it is registered, and treatment of benign prostatic hyperplasia is calibrated to a patient's full urological history and concurrent medications. For travellers and people relocating between countries, prescription requirements, branded packaging, and locally available generics can differ noticeably. Any decision to start, stop, switch, or substitute finasteride should be made together with a healthcare provider familiar with the patient.
